Pubblicazioni scientifiche

Tabiri, S; Kamarajah, SK; Nepogodiev, D; Li, E; Simoes, J; Sravanam, S; Owusu, SA; Mahama, H; Agyeman, YN; Arthur, J; Kunfah, SM; Gyamfi, FE; Owusu, EA; Loffler, MW; Wandoh, P; Bhangu, A; Siaw-Acheampong, K; Argus, L; Chaudhry, D; Dawson, BE; Glasbey, JC; Gujjuri, RR; Jones, CS; Khatri, C; Keatley, JM; Lawday, S; Mann, H; Marson, EJ; Mclean, KA; Picciochi, M; Taylor, EH; Tiwari, A; Simoes, JFF; Trout, IM; Venn, ML; Wilkin, RJW; Dajti, I; Gjata, A; Boccalatte, L; Modolo, MM; Cox, D; Pockney, P; Townend, P; Aigner, F; Kronberger, I; Hossain, K; VanRamshorst, G; Lawani, I; Ataide, G; Baiocchi, G; Buarque, I; Gohar, M; Slavchev, M; Agarwal, A; Brar, A; Martin, J; Olivos, M; Calvache, J; Rivera, CJP; Hadzibegovic, AD; Kopjar, T; Mihanovic, J; Klat, J; Novysedlak, R; Christensen, P; El-Hussuna, A; Batista, S; Lincango, E; Emile, SH; Mengesha, MG; Hailu, DS; Tamiru, H; Kauppila, J; Arnaud, A; Albertsmeiers, M; Lederhuber, H; Loffler, M; Metallidis, S; Tsoulfas, G; Lorena, MA; Grecinos, G; Me, Impact of Bacillus Calmette-Guerin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection, «BJS OPEN», 2021, 5, pp. 1 - 15 [Replica/breve intervento (e simili)]

Rossi R.E.; Milanetto A.C.; Andreasi V.; Campana D.; Coppa J.; Nappo G.; Rinzivillo M.; Invernizzi P.; Modica R.; David A.; Partelli S.; Lamberti G.; Mazzaferro V.; Zerbi A.; Panzuto F.; Pasquali C.; Falconi M.; Massironi S., Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy, «JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION», 2021, 44, pp. 2227 - 2234 [Articolo in rivista]

Zanoni, Lucia; Mattana, Francesco; Calabrò, Diletta; Paccagnella, Andrea; Broccoli, Alessandro; Nanni, Cristina; Fanti, Stefano, Overview and recent advances in PET/CT imaging in lymphoma and multiple myeloma, «EUROPEAN JOURNAL OF RADIOLOGY», 2021, 141, pp. 109793 - 109793 [Articolo in rivista]

Mollica V.; Rizzo A.; Rosellini M.; Marchetti A.; Ricci A.D.; Cimadamore A.; Scarpelli M.; Bonucci C.; Andrini E.; Errani C.; Santoni M.; Montironi R.; Massari F., Bone targeting agents in patients with metastatic prostate cancer: State of the art, «CANCERS», 2021, 13, pp. 1 - 13 [Articolo in rivista] Open Access

Basso U.; Procopio G.; Fornarini G.; Massari F.; Bearz A.; Fratino L.; Milella M.; Bassanelli M.; Ermacora P.; Bimbatti D.; Verzoni E.; Rizzo M.; Porta C., Safety and Efficacy of Tivozanib in First-Line mRCC: A Multicenter Compassionate-Use Study (Meet-Uro 16), «ONCOLOGY», 2021, 99, pp. 747 - 755 [Articolo in rivista]

Mollica, V; Rizzo, A; Massari, F, Adjuvant Nivolumab in Muscle-Invasive Urothelial Carcinoma, «THE NEW ENGLAND JOURNAL OF MEDICINE», 2021, 385, pp. 956 - 957 [Articolo in rivista]

Santoni M.; Piva F.; Porta C.; Bracarda S.; Heng D.Y.; Matrana M.R.; Grande E.; Mollica V.; Aurilio G.; Rizzo M.; Giulietti M.; Montironi R.; Massari F., Artificial Neural Networks as a Way to Predict Future Kidney Cancer Incidence in the United States, «CLINICAL GENITOURINARY CANCER», 2021, 19, pp. 84 - 92 [Articolo in rivista]

Aurilio G.; Cimadamore A.; Lopez-Beltran A.; Scarpelli M.; Massari F.; Verri E.; Cheng L.; Santoni M.; Montironi R., Narrative review: Update on immunotherapy and pathological features in patients with bladder cancer, «TRANSLATIONAL ANDROLOGY AND UROLOGY», 2021, 10, pp. 1521 - 1529 [Articolo in rivista] Open Access

de Velasco G.; Ruiz-Granados A.; Reig O.; Massari F.; Climent Duran M.A.; Verzoni E.; Graham J.; Llarena R.; De Tursi M.; Donskov F.; Iglesias C.; Pandha H.S.; Garcia del Muro X.; Procopio G.; Oudard S.; Castellano D.; Albiges L., Outcomes of systemic targeted therapy in recurrent renal cell carcinoma treated with adjuvant sunitinib, «BJU INTERNATIONAL», 2021, 128, pp. 254 - 261 [Articolo in rivista]

Mollica V.; Marchetti A.; Rosellini M.; Nuvola G.; Rizzo A.; Santoni M.; Cimadamore A.; Montironi R.; Massari F., An insight on novel molecular pathways in metastatic prostate cancer: A focus on ddr, msi and akt, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2021, 22, pp. 1 - 20 [Articolo in rivista] Open Access

Bersanelli M.; Buti S.; Rizzo M.; Cortellini A.; Cattrini C.; Massari F.; Masini C.; Vitale M.G.; Fornarini G.; Caffo O.; Atzori F.; Gatti A.; Macrini S.; Mucciarini C.; Galli L.; Morelli F.; Stellato M.; Fanelli M.; Corti F.; Zucali P.A.; Toscani I.; Dalla Volta A.; Gernone A.; Baldessari C.; La Torre L.; Zara D.; Gennari A.; Bracarda S.; Procopio G.; Porta C., GU-CA-COVID: a clinical audit among Italian genitourinary oncologists during the first COVID-19 outbreak, «THERAPEUTIC ADVANCES IN UROLOGY», 2021, 13, pp. 1 - 6 [Articolo in rivista] Open Access

Rizzo A.; Mollica V.; Massari F., Randomized Clinical Trials in the Era of Precision Oncology - The Role of End Points, Industry Funding, and Medical Writing Integrity, «JAMA ONCOLOGY», 2021, 7, pp. 1577 - 1577 [Articolo in rivista]

Rizzo A.; Mollica V.; Santoni M.; Massari F., Cancer immunotherapy: Current and future perspectives on a therapeutic revolution, «JOURNAL OF CLINICAL MEDICINE», 2021, 10, pp. 1 - 3 [Articolo in rivista] Open Access

Rizzo A.; Mollica V.; Massari F., Considerations Regarding a Network Meta-analysis of Systemic Treatments for Metastatic Castration-Sensitive Prostate Cancer, «JAMA ONCOLOGY», 2021, 7, pp. 1068 - 1068 [Articolo in rivista]

Rizzo A.; Santoni M.; Mollica V.; Logullo F.; Rosellini M.; Marchetti A.; Faloppi L.; Battelli N.; Massari F., Peripheral neuropathy and headache in cancer patients treated with immunotherapy and immuno-oncology combinations: the MOUSEION-02 study, «EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY», 2021, 17, pp. 1455 - 1466 [Articolo in rivista]

Santoni M.; Massari F.; Montironi R.; Battelli N., Manipulating macrophage polarization in cancer patients: From nanoparticles to human chimeric antigen receptor macrophages, «BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER», 2021, 1876, pp. 188547 - 188551 [Articolo in rivista]

Santoni M.; Miccini F.; Cimadamore A.; Piva F.; Massari F.; Cheng L.; Lopez-Beltran A.; Montironi R.; Battelli N., An update on investigational therapies that target STAT3 for the treatment of cancer, «EXPERT OPINION ON INVESTIGATIONAL DRUGS», 2021, 30, pp. 245 - 251 [Articolo in rivista]

Rizzo A.; Rosellini M.; Marchetti A.; Mollica V.; Massari F., Determinants of treatment for first-line immune-based combinations in metastatic renal cell carcinoma: A critical overview of recent evidence, «IMMUNOTHERAPY», 2021, 13, pp. 685 - 692 [Articolo in rivista]

Marchetti A.; Rosellini M.; Rizzo A.; Mollica V.; Battelli N.; Massari F.; Santoni M., An up-to-date evaluation of cabozantinib for the treatment of renal cell carcinoma, «EXPERT OPINION ON PHARMACOTHERAPY», 2021, 22, pp. 2323 - 2336 [Articolo in rivista]

Massari F.; Rizzo A.; Mollica V.; Santoni M., A brand-new CAR for macrophages: Is it time to fire up the engines of a new era for the treatment of renal cell carcinoma?, «FUTURE ONCOLOGY», 2021, 17, pp. 1839 - 1841 [Articolo in rivista]